{
    "2019-03-17": [
        [
            {
                "time": "2023-10-18",
                "original_text": "AUGUSTUS Demonstrates Favorable Safety Results of EliquisÂ® Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention",
                "features": {
                    "keywords": [
                        "Eliquis",
                        "Vitamin K Antagonists",
                        "Non-Valvular Atrial Fibrillation",
                        "Acute Coronary Syndrome",
                        "Percutaneous Coronary Intervention",
                        "Favorable Safety Results"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}